Clinical trial Recruiting at 39 sites Interventional Ages 18 and up

Comparing Non-Invasive Ventilation and High-Flow Nasal Oxygen for Respiratory Failure

Official title: Non-Invasive Ventilation Versus High-flow Nasal Oxygen for Post-extubation Respiratory Failure in Intensive Care Units: a Multicenter, Randomized, Controlled Trial

Run by Poitiers University Hospital · NCT05686850 · Data updated 2026-11-12

This study is testing whether using non-invasive ventilation or high-flow nasal oxygen can help ICU patients who have trouble breathing after being taken off a ventilator.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment670 (estimated)
SponsorPoitiers University Hospital
Academic / other
Locations47 sites (Brussels and 46 other locations)
StatusRecruiting
StartedFebruary 2, 2023
Main results expectedFebruary 27, 2028
Study endsAugust 27, 2028
Registry record updatedMay 26, 2026
Trial IDNCT05686850 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients who have undergone more than 24 hours of invasive mechanical ventilation and develop respiratory failure within seven days after extubation.

Probably not a fit

Patients who do not experience respiratory failure after extubation or those who have not been on invasive mechanical ventilation for the required duration may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of non-invasive ventilation (NIV) and high-flow nasal oxygen in treating post-extubation respiratory failure in intensive care unit patients. Approximately 20% of patients experience respiratory failure after extubation, with a significant risk of reintubation and high mortality rates. The study will assess whether alternating between NIV and high-flow nasal oxygen can improve outcomes compared to standard oxygen therapy. The trial will include patients who have been on invasive mechanical ventilation for more than 24 hours and develop respiratory failure within seven days post-extubation.

Why it matters

Potential benefit: If successful, this study could provide a more effective non-invasive treatment option for patients experiencing respiratory failure after extubation.

How similar studies have gone: While previous studies have indicated risks associated with NIV, this approach of comparing NIV with high-flow nasal oxygen specifically for post-extubation respiratory failure has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Duration of invasive mechanical ventilation of more than 24h in the ICU before extubation.
* Post-extubation respiratory failure occurring within the first 7 days after extubation (see criteria below). As in several previous studies, post-extubation respiratory failure will be defined by the presence of the 2 following criteria combining a clinical criterion and a blood gas criterion:

  * Clinical criterion persisting for at least 30 minutes: a respiratory rate exceeding 25 breaths per minute or clinical signs of respiratory distress with increased accessory muscle activity.
  * Blood gas criterion: Hypoxemia defined as PaO2/FiO2 ratio below 150 mm Hg or respiratory acidosis defined as pH below 7.35 units and PaCO2 above 45 mm Hg. For patients under standard oxygen, FiO2 will calculated according to the following formula: FiO2 = 0.21 + 0.03 x (oxygen flow L/min).
* Informed consent from the relatives or the patient himself, or emergency inclusion procedure in case of inability of patient or proxy to give consent.

Exclusion Criteria:

* NIV at home
* ICU admission for peripheral neuromuscular disease type Guillain-Barré syndrome or myasthenia gravis.
* Upper airway obstruction as main reason for post-extubation respiratory failure
* Urgent need for reintubation (respiratory or cardiac arrest, respiratory pauses with loss of consciousness or gasping for air, or severe hypoxemia defined as SpO2 lower than 90% despite maximal oxygen support)
* Altered consciousness (Glasgow coma scale \< 12)
* Unplanned extubation (accidental or self-extubation)
* Do-not-reintubate order at time of respiratory failure
* Patient previously included in the study
* People under protection (minors, persons deprived of liberty by a judicial or administrative decision, adults under law protection)
* Patient not affiliated to health care system.

Where it's running

  • Erasme Hospital
    Brussels, Belgium
    Recruiting
  • Angers University Hospital
    Angers, France
    Recruiting
  • Victor Dupouy Hospital
    Argenteuil, France
    Recruiting
  • Henri Mondor Hospital
    Aurillac, France
    Recruiting
  • Henri Duffaut Hospital
    Avignon, France
    Recruiting
  • Nord-Franche-Comté Hospital
    Belfort, France
    Recruiting
Show 41 more locations
  • Fleyriat Hospital
    Bourg-en-Bresse, France
    Recruiting
  • Brest University Hospital
    Brest, France
    Recruiting
  • Clermont-Ferrand University Hospital
    Clermont-Ferrand, France
    Recruiting
  • Louis Mourier Hospital
    Colombes, France
    Recruiting
  • Cèdres Clinic
    Cornebarrieu, France
    Recruiting
  • Henri Mondor Hospital
    Créteil, France
    Recruiting
  • Francois Mitterrand Hospital
    Dijon, France
    Recruiting
  • Grenoble University Hospital
    Grenoble, France
    Recruiting
  • Vendée Hospital
    La Roche-sur-Yon, France
    Recruiting
  • La Rochelle Hospital
    La Rochelle, France
    Recruiting
  • André Mignot Hospital
    Le Chesnay, France
    Recruiting
  • Le Mans Hospital
    Le Mans, France
    Recruiting
  • Lens Hospital
    Lens, France
    Recruiting
  • Lille University Hospital
    Lille, France
    Recruiting
  • Limoges University Hospital
    Limoges, France
    Recruiting
  • Saint Joseph Saint Luc Hospital
    Lyon, France
    Recruiting
  • La Timone Hospital
    Marseille, France
    Recruiting
  • Moulins-Yzeure Hospital
    Moulins, France
    Recruiting
  • Emile Muller Hospital
    Mulhouse, France
    Recruiting
  • Nantes University Hospital
    Nantes, France
    Recruiting
  • Nice University Hospital
    Nice, France
    Recruiting
  • Orléans University Hospital
    Orléans, France
    Recruiting
  • La Pitié Salpêtrière Hospital
    Paris, France
    Recruiting
  • Pau Hospital
    Pau, France
    Recruiting
  • Poitiers University Hospital
    Poitiers, France
    Recruiting
  • Rennes University Hospital
    Rennes, France
    Recruiting
  • Rouen University Hospital
    Rouen, France
    Recruiting
  • Saint Nazaire Hospital
    Saint-Nazaire, France
    Recruiting
  • Saintes Hospital
    Saintes, France
    Recruiting
  • Foch Hospital
    Suresnes, France
    Recruiting
  • Tours University Hospital
    Tours, France
    Recruiting
  • Vannes Hospital
    Vannes, France
    Recruiting
  • Pierre Zobda Quitman Hospital
    Fort-de-France, Martinique
    Recruiting
  • Bordeaux University Hospital
    Bordeaux, France
    Withdrawn
  • Dax Hospital
    Dax, France
    Withdrawn
  • Mont de Marsan Hospital
    Mont-de-Marsan, France
    Withdrawn
  • Felix Guyon Hospital
    Saint-Denis, Reunion
    Terminated
  • Hospital de La Santa Creu I Sant Pau
    Barcelona, Spain
    Not yet recruiting
  • Hospital Universitari de Bellvitge
    L'Hospitalet de Llobregat, Spain
    Not yet recruiting
  • Hospital Universitario Central de Asturias
    Oviedo, Spain
    Not yet recruiting
  • Complejo Hospitalario Universitario de Toledo
    Toledo, Spain
    Terminated

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.